4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-039023
Chief Scientific Officer sold 33,300 shares at an average $46.54 ($1,549,813)
- Chief Scientific Officer acquired 33,300 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
ROBINS HARLAN S · Chief Scientific Officer
Table I: Non-derivative
10 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-06-23 | Exercise or conversion : show line 1 in the form | +11,100 | $6.32 | $70,152 | 11,779 | D |
| 2020-06-23 | Sale : show line 2 in the form | −1,500 | $46.21 | $69,315 | 10,279 | D |
| 2020-06-23 | Sale : show line 3 in the form | −9,600 | $46.95 | $450,720 | 679 | D |
| 2020-06-24 | Exercise or conversion : show line 4 in the form | +11,100 | $6.32 | $70,152 | 11,779 | D |
| 2020-06-24 | Sale : show line 5 in the form | −8,277 | $45.72 | $378,424 | 3,502 | D |
| 2020-06-24 | Sale : show line 6 in the form | −2,823 | $46.38 | $130,931 | 679 | D |
| 2020-06-25 | Exercise or conversion : show line 7 in the form | +11,100 | $6.32 | $70,152 | 11,779 | D |
| 2020-06-25 | Sale : show line 8 in the form | −700 | $45.36 | $31,752 | 11,079 | D |
| 2020-06-25 | Sale : show line 9 in the form | −6,657 | $46.84 | $311,814 | 4,422 | D |
| 2020-06-25 | Sale : show line 10 in the form | −3,743 | $47.25 | $176,857 | 679 | D |
| Open-market sales · 33,300 sh · avg $46.54 · $1,549,813 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-06-23 | Exercise or conversion : show line 11 in the form Stock Option (Right to Buy) | −11,100 | 422,400 | D |
| 2020-06-24 | Exercise or conversion : show line 12 in the form Stock Option (Right to Buy) | −11,100 | 411,300 | D |
| 2020-06-25 | Exercise or conversion : show line 13 in the form Stock Option (Right to Buy) | −11,100 | 400,200 | D |
Loading xslF345X03/doc4.xml…